Safety margins

≥ 18 years

Weight	ROA	Dosage
	ROA: po	Dosage: min. 250mg 4 dd to max. 1000mg 4 dd
	ROA: iv	Dosage: min. 250mg 4 dd to max. 1000mg 4 dd

Kidney function

Renal elimination: 2-15%

Dosage: independent on kidney function

Interactions

Interaction with (ATC):	Expected effect:
Interaction with (ATC): N03AF01 - Carbamazepine	Expected effect: verhoging plasmaconcentratie carbamazepine
Interaction with (ATC): L04AD01 - Ciclosporin	Expected effect: verhoging concentratie ciclosporine
Interaction with (ATC): L04AD02 - Tacrolimus	Expected effect: verhoging concentratie tacrolimus
Interaction with (ATC): L04AA10 - Sirolimus	Expected effect: verhoging concentratie sirolimus
Interaction with (ATC): R06AX12 - Terfenadine	Expected effect: toename cardiotoxiciteit
Interaction with (ATC): A03FA02 - Cisapride	Expected effect: toename cardiotoxiciteit
Interaction with (ATC): C01BA03 - Disopyramide	Expected effect: toename cardiotoxiciteit
Interaction with (ATC): C01AA05 - Digoxin	Expected effect: verhoging plasmaconcentratie digoxine
Interaction with (ATC): R03DA04 - Theophylline	Expected effect: verhoging plasmaconcentratie theofylline
Interaction with (ATC): J05AE - Protease Inhibitors	Expected effect: verhoging plasmaconcentratie erytromycine

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

• http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
• http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16

For individual advice, consult an expert on site.

General comments

CVVH: geen aanpassing nodig

Metadata

Swab vid: M-1388.1
Updated: 09/19/2019 - 11:56
Status: Published

External links

• Farmacotherapeutisch Kompas - Erytromycine (systemisch)

Menu position

• antibacterial